设计源头和管道末端生物技术,以应对制药污染
Vladimir Akhrimenko1, Klaus Kümmerer2, Sixto Malato3
1Basque Sustainable Pharmacy and Biotherapy Research Group, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain; Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.
Trends in biotechnology
|December 19, 2025
概括
活性药物成分 (API) 的制药污染威胁着生态系统. 有效的解决方案需要减少来源,先进的废水处理,并利用生物技术保护环境.
科学领域:
- 环境科学 环境科学
- 生态毒理学 生态毒理学
- 公共卫生 公共卫生
背景情况:
- 制药污染是一个广泛的环境问题.
- 活性药物成分 (API),代谢物和辅料对公众健康和生态系统构成风险.
- 欧洲立法现在将某些API确定为优先污染物,强制要求先进的废水处理.
研究的目的:
- 为了应对制药污染的挑战.
- 突出需要综合解决方案的需要.
- 探索新兴生物技术的潜力.
主要方法:
- 审查当前的环境立法和挑战.
- 对制药污染源和影响的分析.
- 识别潜在的技术解决方案.
主要成果:
- 制药污染是一个重大的环境威胁.
- 源头和管道末端战略的结合是必要的.
- 先进的生物技术提供了有希望但未被充分探索的减缓途径.
结论:
- 解决制药污染问题需要采取多方面的方法.
- 必须加强目前的废水处理.
- 对基因工程和生物传感器等生物技术的进一步研究和应用对于有效的制药污染控制至关重要.
相关概念视频
Bioremediation
22.0K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
22.0K
Environmental Applications of Microorganisms
903
Microorganisms play a pivotal role in maintaining ecosystem balance by recycling essential elements such as carbon, nitrogen, and phosphorus, as well as supporting processes like bioremediation, wastewater treatment, and biofuel production.Microbes in Elemental CyclesIn the carbon cycle, microorganisms decompose organic matter, releasing carbon dioxide via aerobic respiration. This carbon dioxide is subsequently used by photosynthetic organisms to synthesize organic compounds, closing the...
903
Biological Methods for Microbial Control
758
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
758
Drug Biotransformation: Overview
3.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.5K
Biopharmaceutical Factors Influencing Drug Product Design: Overview
218
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
218
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
152
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
152


